We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Medtronic

Medtronic offers medical products and therapies for the treatment of cardiac and vascular diseases, diabetes, and neu... read more Featured Products: More products

Download Mobile App




Remote Monitoring System Helps Identify Cardiac Symptoms

By HospiMedica International staff writers
Posted on 07 Oct 2014
An external, wire-free, adhesive heart monitor helps detect and diagnose the cause of irregular heartbeats.

The SEEQ Mobile Cardiac Telemetry (MCT) system is indicated for patients who experience symptom—such as syncope, lightheadedness, vertigo, palpitations, or shortness of breath—that are indicative of an irregular heartbeat, but are not detected by a 24-hour Holter monitor. More...
The water-resistant adhesive sensor monitors the heart continuously for up to 30 days, and since it has a slim profile and no wires it can be worn discreetly, so that patients can be monitored even while exercising, showering, or sleeping.

Automatically activated when applied to the skin, the SEEQ MCT remotely monitors every heartbeat and automatically sends important cardiac data to a dedicated data center staffed by cardiographic technicians who provide continuous, round-the-clock cardiac monitoring. And while the system captures and transmits cardiac data automatically, a trigger button also allows patients to alert the monitoring center, should they have symptoms.

Whichever way the trigger is activated, data are transmitted via Bluetooth and cellular connections to the monitoring center, operated by Medtronic Monitoring, which provides reports to prescribing physicians for review and analysis. The SEEQ MCT system and Medtronic Monitoring Center are products and services of Medtronic (Minneapolis, MN, USA).

“By adding a short-term cardiac monitor to complement our insertable long-term Reveal LINQ device, Medtronic is providing a comprehensive portfolio of diagnostic tools to help patients with different types of symptoms,” said Nina Goodheart, vice president and general manager of the diagnostics and monitoring business at Medtronic. “The SEEQ MCT System and Medtronic Monitoring Center give patients a simple, easy-to-use, short-term diagnostic solution while ensuring that important cardiac data are captured so that physicians can make timely and actionable diagnoses.”

“The SEEQ MCT system allows us to get the critical arrhythmia recordings we need to make treatment decisions without being burdensome to patients,” said electrophysiologist Ethan Levine, DO, director of electrophysiology and arrhythmia services at Arnot Ogden Medical Center (Elmira, NY, USA). “Wearing a bulky monitor for more than a couple of days can be a frustrating experience for patients. Because this device is an inconspicuous and easy-to-use adhesive patch, patients are more likely to wear it continuously, allowing for more consistent and comprehensive capturing of data, which enables physicians to make accurate diagnoses and timely treatment plans.”

While the SEEQ MCT System is prescribed for patients who may require up to 30 days of monitoring, Medtronic also offers the Reveal LINQ insertable cardiac monitoring (ICM) system, which is designed for those whose cardiac arrhythmias are less frequent, and may not be detected by short-term monitoring systems. The Reveal LINQ ICM can continuously monitor patients for up to three years.

Related Links:

Medtronic



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
ow Frequency Pulse Massager
ET10 L
Head Rest
Medifa 61114_3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.